πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7579444

Polymer-factor IX moiety conjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576065

Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concu

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563593

Method for preparing cell cultures from biological specimens for assaying secreted factors

Precision Therapeutics, Inc. Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560265

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544661

Self-assembling peptide amphiphiles and related methods for growth factor delivery

Northwestern University Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534613

Methods of treating parkinson's disease using viral vectors

The Regents of the University of California Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531352

Inducible plasmid vector encoding TGF-Ξ² and use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7491798

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, c

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7459534

Inactivation resistant factor VIII

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7431929

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7432093

Soluble, functional apoptotic protease-activating factor 1 fragments

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427671

Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides f

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7425329

Methods for treating bone cancer pain by administering a nerve growth factor antagonist

Regents of the University of Minnesota Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7425449

Site specific Listeria integration vectors and methods for using the same

The Regents of the University of California Β· Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410363

Electrical connector having compliant biasing device

Hon Hai Precision Ind. Co., Ltd. Β· Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390646

Bacterial vectors and methods of use thereof

The Regents of the University of California Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7387896

MicroRNA vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378273

Expression vectors

Gala Design, Inc. Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365171

Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities

Beijing Medical University United Biological Engineering Company Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7351411

Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7319134

Regulation of transcription factor, NF-IL6/LAP

The Regents of the University of California Β· Granted Tue Jan 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted